Healthcare >> CEO Interviews >> May 3, 2004
LEONARD P. SHAYKIN has served as Chairman of the Board since June 1993,
and Chairman and Chief Executive Officer since August 1999 at NaPro
BioTherapeutics, Inc. In 1995, Mr. Shaykin founded Shaykin & Co., LLC, a
private investment and management company. Prior to founding Shaykin &
Co., Mr. Shaykin was a managing partner of Adler & Shaykin, an
investment partnership organized to sponsor management leveraged
buyouts. Prior to that, Mr. Shaykin was Vice President, Director and a
member of the Investment Committee of Citicorp Venture Capital, Ltd. and
Citicorp Capital Investors, Inc., the venture capital and equity
investment subsidiaries of Citicorp and Citibank. He is currently a
Board Member of the Friends of Sheba Medical Center-Tel Hashomer,
Israel, and a trustee of the Jackson Laboratories, a not-for-profit
genetic research institute. Mr. Shaykin received a BA and an MA from the
University of Chicago, and an MBA from the University of Chicago
Graduate School of Business. Profile
Mr. Shaykin: NaPro is a pharmaceutical company focused primarily on the
development of therapies for the treatment of oncology
